Market Introduction
Protein expression is a process in which proteins are synthesized, modified and regulated. Protein expression involves laboratory techniques & procedures which aid in manufacture of proteins. The technique allows to produce and purify the desired protein, either inside or outside a cell. The proteins synthesized using protein expression technique can be used for industrial processes or to diagnose and to treat diseases.
Thus, the growing adoption of precision medicines are expected to create a significant demand for protein expression in the coming years, which is further anticipated to drive the protein expression market.
The current COVID-19 pandemic has produced a huge immediate demand for SARS-CoV-2 RNA/protein-based diagnostic reagents and associated antibodies, putting tremendous strain on the supply and distribution chain. By achieving rapid, larger-scale production, complemented by long-term higher volume production in transgenic plants, transient expression in plants may resolve the shortage. For example, on Dec. 2020, Clover Biopharmaceuticals, a China-based biotechnology company, announced positive clinical data from its Phase 1 trial demonstrating that its protein-based COVID-19 S-Trimer vaccine candidates in combination with adjuvants from either GSK induce strong immune responses, including neutralizing antibodies and cell-mediated immunity, as well as favorable safety and tolerability profiles in 150 adult and elderly participants. However, in long run the market has strong potential to boost the growth rate as Asia Pacific is most populated region in the world and where high number of Covid 19 cases detected. Also, the prevalence of other infectious diseases and cancer cases.
Market Overview and Dynamics
The Protein expression market in Asia Pacific is expected to grow from US$ 461.2 million in 2021 to US$ 869.7 million by 2028; it is estimated to grow at a CAGR of 9.5% from 2021 to 2028. The COVID-19 pandemic has led to significant health, social, and economic crises. The development of a vaccine for COVID-19 is an effective strategy to control the outbreak. It is required that the vaccine is produced at high speed and is easily scalable. Recombinant protein, viral-vectored or nucleic acid-based (recombinant plasmid DNA and mRNA) vaccines need to be considered to shorten the vaccine production timeframe. The use of protein expression is increasing during vaccine development due to the advantages of recombinant protein, which drives the growth of the protein expression market.
Key Market Segments
In terms of product, the reagents segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of services, the antibody development and production segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of application, the therapeutic segment accounted for the largest share of the Asia Pacific protein expression market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the Asia Pacific protein expression market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the protein expression market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., GenScript, Merck KGaA, Agilent Technologies, Inc., Takara Bio Inc., Bio-Rad Laboratories Inc., QIAGEN, New England Biolabs, and Promega Corporation.
Reasons to buy report
ASIA PACIFIC PROTEIN EXPRESSION MARKET SEGMENTATION
By Product
By Services
By Application
By End User
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 461.2 Million |
| Market Size by 2028 | US$ 869.7 Million |
| CAGR (2021 - 2028) | 9.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Protein Expression Market is valued at US$ 461.2 Million in 2021, it is projected to reach US$ 869.7 Million by 2028.
As per our report Asia Pacific Protein Expression Market, the market size is valued at US$ 461.2 Million in 2021, projecting it to reach US$ 869.7 Million by 2028. This translates to a CAGR of approximately 9.5% during the forecast period.
The Asia Pacific Protein Expression Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Protein Expression Market report:
The Asia Pacific Protein Expression Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Protein Expression Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Protein Expression Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Protein Expression Market
